* SYNEO synbiotic blend: Bifidobacterium breve M-16V (probiotic) & short and long-chain galacto- and/or fructo-oligosaccharides (prebiotic). The only synbiotic blend within hypoallergenic formulas in the UK.
†Aptamil Pepti Syneo and Neocate Syneo contain more of the gut microbiota modulating factors in breastmilk (Prebiotic oligosaccharides [short and long-chain galacto- and/or fructo-oligosacharides], probiotic bacteria [Bifidobacterium breve M-16V] and lactose [Aptamil Pepti Syneo only]) than any other hypoallergenic formulas in the UK.
‡12 week RCT.6 Infants with Atopic Dermatitis, Aptamil Pepti Syneo vs non-synbiotic EHF; Systematic review and meta-analysis of 4 RCTs7, Neocate Syneo vs Neocate LCP (Nov 2020); Single arm UK non-IgE mediated CMA study14, baseline non-synbiotic formula (n=27 out of n=29 well established on a non-synbiotic EHF) vs Aptamil Pepti Syneo, 4 week intervention. Follow-up arm of study n=13; 1 year follow up8 from 12 week RCT6; Observational study of real-world evidence in The Health Improvement Network (THIN) GP database15, n=148 Neocate Syneo vs Alfamino (Feb 2021).
1. Market comparison of UK EHF and AAF data cards, September 2023.
2. Candy, et al. Pediatr Res. 2018;83(3):677–86.
3. Abrahamse-Berkeveld, et al. J Nutr Sci. 2016;5:e42.
4. Burks, et al. Pediatr Allergy Immunol.2015;26(4):316–22.
5. Fox, et al. Clin Transl Allergy. 2019;9:5.
6. van der Aa, et al. Clin Exp Allergy. 2010;40(5):795–804.
7. Sorensen, et al. Nutrients. 2021;13(3):935.
8. van der Aa, et al. Allergy. 2011;66(2):170-7.
9. Martin, et al. Benef Microbes. 2010;1(4):367–82.
10. Wopereis, et al. Pediatr Allergy Immunol. 2014;25(5):428–38.
11. Harvey, et al. Pediatr Res. 2014;75(2):343–51.
12. Walker, et al. Pediatr Res. 2015;77(1):220–8.
13. West, et al. J Allergy Clin Immunol. 2015;135(1):3-13.
14. Hubbard, et al. Immun Inflamm Dis. 2022;10(6):e636.
15. Sorensen, et al. Nutrients. 2021;13(7):2205.
Please ensure your role and areas of interest are up to date.